Exchange: NASDAQ·Updated 10:56 AM EDT
PMVP logo

PMVP PMV Pharmaceuticals Inc

$1.32
$0.08
(6.45%)
Today
Reported EarningsAug 14
Mkt Cap$66.29M
Vol149,089.00

About PMVP

PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.
52

Neutral Sentiment

How do you feel about PMVP?

Advertisement|Remove ads.